Abstract: Obstructive sleep apnea (OSA) is a chronic and prevalent condition with well-established comorbidities. However, many severe cases remain undiagnosed due to poor access to polysomnography ...

Among adults with mild to severe obstructive sleep apnea, those receiving AD109, an oral combination drug, vs. placebo ...

A large phase 3 clinical trial has revealed promising results for a once-nightly pill designed to treat obstructive sleep ...

Nearly 70% of patients with positional obstructive sleep apnea who discontinued positional therapy after achieving disease ...

Abstract: Obstructive sleep apnea (OSA) is a sleep disorder that causes partial or complete cessation of breathing during an individual's sleep. Various methods have been proposed to automatically ...

You snore because your airway was redesigned for language. That structural trade-off has been with us for 40,000 years.

A University of Toronto professor’s research on the physiology of sleep and breathing has paved the way for a new sleep apnea treatment that recently reported positive results in a phase 3 clinical ...

For nearly 25 years, Stillwater Medical Center employee Shyla Eggers has helped tell the stories of patients, physicians and new advancements in healthcare technology throughout the community.

A University of Toronto professor's research on the physiology of sleep and breathing has paved the way for a new sleep apnea treatment that recently ...

Introduction: Obstructive sleep apnea syndrome is a common condition in childhood and if left untreated can result in many health problems. An accurate diagnosis of the etiology is crucial for ...

Sleep breathing disorders (SBDs)—including obstructive sleep apnoea, central sleep apnoea and sleep-related hypoventilation syndromes—represent a major yet under-recognised contributor to global ...

A once-nightly oral pill helped control obstructive sleep apnea in a large, Phase III clinical trial presented at the 2026 ATS International Conference. The drug, called AD109, is the first therapy to ...